Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Hemodialysis Extraction Ratio

Known as: HDER 
The determination of the fractional content of a substance removed from the blood during a hemodialysis session.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Background: Numerous scales exist for classification of major bleeding events. There are limited data comparing the most commonly… Expand
Is this relevant?
2018
2018
Background and Purpose— Edoxaban is a direct oral factor Xa inhibitor with proven efficacy and safety among patients with atrial… Expand
  • figure 1
  • table 1
  • figure 2
  • table 2
  • figure 3
Is this relevant?
2018
2018
BACKGROUND Peri-operative management of anticoagulated patients with atrial fibrillation (AF) is challenging. To gain information… Expand
Is this relevant?
2017
2017
BACKGROUND Atrial fibrillation (AF) ablation procedures are increasingly being performed in patients receiving direct oral… Expand
Is this relevant?
Highly Cited
2016
Highly Cited
2016
Background: Edoxaban, an oral factor Xa inhibitor with 50% renal clearance, was noninferior to well-managed warfarin for stroke… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • table 2
Is this relevant?
Highly Cited
2016
Highly Cited
2016
Background We studied the concomitant use of single antiplatelet therapy (SAPT) on the efficacy and safety of the anti‐Xa agent… Expand
  • figure 1
  • table 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
2016
2016
Background and Purpose— Patients with atrial fibrillation and previous ischemic stroke (IS)/transient ischemic attack (TIA) are… Expand
  • table 1
  • table 2
  • figure 1
  • table 3
  • figure 2
Is this relevant?
2016
2016
AIMS In the ENGAGE AF-TIMI 48 trial, edoxaban, a factor Xa inhibitor, was not found to be inferior to warfarin for the prevention… Expand
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2010
2010
ABSTRACT Little is known about raltegravir removal by hemodialysis in patients with end-stage renal disease (ESRD). We therefore… Expand
  • table 1
Is this relevant?